Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 140Myelodysplastic Syndromes 123Myeloproliferative Disorders 103Leukemia, Myeloid, Acute 99Leukemia 67Precursor Cell Lymphoblastic Leukemia-Lymphoma 53Multiple Myeloma 52Lymphoma 49Primary Myelofibrosis 43Polycythemia Vera 43Leukemia, Lymphocytic, Chronic, B-Cell 40Lymphoma, Non-Hodgkin 39Hodgkin Disease 35Leukemia, Myelomonocytic, Chronic 31Thrombocythemia, Essential 30Leukemia, Myeloid, Chronic-Phase 30Hematologic Neoplasms 29Neoplasms 27Lymphoma, Follicular 27Mastocytosis 26Myelodysplastic-Myeloproliferative Diseases 24Lymphoma, Large B-Cell, Diffuse 23Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 23Leukemia, Myeloid, Accelerated Phase 23Blast Crisis 23Neoplasms, Plasma Cell 22Congenital Abnormalities 22Lymphoma, Mantle-Cell 21Lymphoma, B-Cell, Marginal Zone 21Leukemia, Hairy Cell 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Piebaldism × Myeloid × Clear all
NCT00336076 2016-11-07

Molecular Mechanisms and Diagnosis of Mastocytosis

University of Michigan

Completed
136 enrolled
Myeloid

Mast Cell Activation Disorders, Anaphylaxis, Mastocytosis, Piebaldism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡